Cytomegalovirus infection epidemiology and demographics: Difference between revisions
m (Bot: Removing from Primary care) |
|||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Worldwide, approximately 40,000 to 90,000 per 100,000 individuals are seropositive for Cytomegalovirus infection. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
| Line 20: | Line 20: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Emergency medicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Ophthalmology]] | |||
Latest revision as of 21:12, 29 July 2020
|
Cytomegalovirus infection Microchapters |
|
Differentiating Cytomegalovirus infection from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Cytomegalovirus infection epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Cytomegalovirus infection epidemiology and demographics |
|
FDA on Cytomegalovirus infection epidemiology and demographics |
|
CDC on Cytomegalovirus infection epidemiology and demographics |
|
Cytomegalovirus infection epidemiology and demographics in the news |
|
Blogs on Cytomegalovirus infection epidemiology and demographics |
|
Risk calculators and risk factors for Cytomegalovirus infection epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Kuchkuntla, M.B.B.S[2]
Overview
Worldwide, approximately 40,000 to 90,000 per 100,000 individuals are seropositive for Cytomegalovirus infection.
Epidemiology and Demographics
Prevalence
- Worldwide, approximately 40,000 to 90,000 per 100,000 individuals are seropositive for Cytomegalovirus infection. [1]
- CMV seroprevalence in developing countries reaches more than 90% by adolescence and exceeds 95% by early adulthood
Gender
- In the United States, 35%-90% of women entering their childbearing years are seropositive, and thus, they are not susceptible to primary CMV infection.
Age
- Seroprevalence is age-dependent 58.9% of individuals aged 6 and over are infected with CMV.
- 90.8% of individuals aged 80 and over are positive for CMV.
References
- ↑ Pytka D, Czarkowska-Pączek B| title=[CMV infection in elderly]. | journal=Przegl Lek | year= 2016 | volume= 73 | issue= 4 | pages= 241-4 | pmid=27526428 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27526428 }}